Your browser doesn't support javascript.
loading
MUC1 promotes glioblastoma progression and TMZ resistance by stabilizing EGFRvIII.
Tong, Fei; Zhao, Ji-Xing; Fang, Zi-Yuan; Cui, Xiao-Teng; Su, Dong-Yuan; Liu, Xing; Zhou, Jun-Hu; Wang, Guang-Xiu; Qiu, Zhi-Jun; Liu, Shi-Zhong; Fu, Jun-Qi; Kang, Chun-Sheng; Wang, Jia-Chong; Wang, Qi-Xue.
Afiliação
  • Tong F; Tianjin Medical University General Hospital, Tianjin 300052, China; Tianjin Neurological Institute, Key Laboratory of Neurotrauma, Variation, and Regeneration, Ministry of Education and Tianjin Municipal Government, Tianjin 300052, China.
  • Zhao JX; Tianjin Medical University General Hospital, Tianjin 300052, China; Tianjin Neurological Institute, Key Laboratory of Neurotrauma, Variation, and Regeneration, Ministry of Education and Tianjin Municipal Government, Tianjin 300052, China.
  • Fang ZY; Clinical Medical College, Hebei University, Baoding 071000, China.
  • Cui XT; Tianjin Medical University General Hospital, Tianjin 300052, China; Tianjin Neurological Institute, Key Laboratory of Neurotrauma, Variation, and Regeneration, Ministry of Education and Tianjin Municipal Government, Tianjin 300052, China.
  • Su DY; Tianjin Medical University General Hospital, Tianjin 300052, China; Tianjin Neurological Institute, Key Laboratory of Neurotrauma, Variation, and Regeneration, Ministry of Education and Tianjin Municipal Government, Tianjin 300052, China.
  • Liu X; Beijing Neurosurgical Institute, Capital Medical University, Beijing 100050, China.
  • Zhou JH; Tianjin Medical University General Hospital, Tianjin 300052, China; Tianjin Neurological Institute, Key Laboratory of Neurotrauma, Variation, and Regeneration, Ministry of Education and Tianjin Municipal Government, Tianjin 300052, China.
  • Wang GX; Tianjin Medical University General Hospital, Tianjin 300052, China; Tianjin Neurological Institute, Key Laboratory of Neurotrauma, Variation, and Regeneration, Ministry of Education and Tianjin Municipal Government, Tianjin 300052, China.
  • Qiu ZJ; Tianjin Medical University General Hospital, Tianjin 300052, China.
  • Liu SZ; Tianjin Medical University General Hospital, Tianjin 300052, China.
  • Fu JQ; Department of Neurosurgery, Haikou Affiliated Hospital of Xiangya Medical College, Central South University, Hainan 570311, China; Department of Neurosurgery, Haikou People's Hospital, Hainan 570208, China.
  • Kang CS; Tianjin Medical University General Hospital, Tianjin 300052, China; Tianjin Neurological Institute, Key Laboratory of Neurotrauma, Variation, and Regeneration, Ministry of Education and Tianjin Municipal Government, Tianjin 300052, China. Electronic address: kang97061@tmu.edu.cn.
  • Wang JC; Department of Neurosurgery, Haikou Affiliated Hospital of Xiangya Medical College, Central South University, Hainan 570311, China; Department of Neurosurgery, Haikou People's Hospital, Hainan 570208, China. Electronic address: wjc1972@163.com.
  • Wang QX; Tianjin Medical University General Hospital, Tianjin 300052, China; Tianjin Neurological Institute, Key Laboratory of Neurotrauma, Variation, and Regeneration, Ministry of Education and Tianjin Municipal Government, Tianjin 300052, China. Electronic address: qixue_wang@tmu.edu.cn.
Pharmacol Res ; 187: 106606, 2023 01.
Article em En | MEDLINE | ID: mdl-36516884
Assuntos
Palavras-chave
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Glioma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Pharmacol Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioblastoma / Glioma Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Pharmacol Res Assunto da revista: FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China